Diode laser endoscopic cyclophotocoagulation in the normal equine eye.

The research article explores the effects of diode endoscopic cyclophotocoagulation (ECP), a possible treatment for glaucoma, on a horse’s eye. The study found noticeable tissue changes and damage to the target ciliary epithelium at multiple energy levels, with potential side effects including inflammation, reduced intraocular pressure, and cataract development.

Research Methodology

The study was carried out in two key phases.

• In Phase I, 10 equine cadaver eyes were experimented on with varying energy levels of the ECP procedure, while assessing the subsequent visible and histologic ciliary process changes.
• Phase II was conducted on four live normal adult horses. Again, distinct energy levels of the ECP procedure were utilised and visible tissue damage analysed. Furthermore, the contralateral eye of each horse underwent a sham operation (a fake procedure intended to mimic the real one), perhaps to establish a baseline or to check for placebo effects.

Study Outcomes

Multiple key outcomes were established throughout the study:

• The average combined angle of reach (AR) for the ECP probe was found to be 162 ± 29 degrees.
• Observable tissue changes were apparent at each energy level tested, with degrees of tissue ‘popping’ (the breaking or destruction of tissue during laser treatment) observed at higher energy levels.
• Tissue damage, both visible and histologic, occurred with every energy setting used.
• Several clinical effects were noticed following ECP treatment, including acute inflammation, intraocular pressure reduction, cataract formation, corneal edema, corneal ulceration, and hypertensive responses.

Conclusions

The researchers concluded that Diode ECP, particularly between 0.90 and 1.14 J, could be a viable treatment option for horses with glaucoma. This conclusion was based on observed changes to visible tissue and damage inflicted on the target ciliary epithelium. However, potential side effects, particularly the development of cataracts, could limit the usefulness of this treatment given its adverse effect on the eye’s anterior chamber.